Frequency and prognostic significance of atrial fibrillation in acute pulmonary embolism: A pooled analysis

Abstract

ObjectiveTo summarize data on the prevalence/incidence, risk factors and prognosis of atrial fibrillation (AF) in patients with acute pulmonary embolism (aPE). MethodsMEDLINE, Embase, and Web of Science were searched to identify all published studies providing relevant data through December 12, 2021. Random-effects meta-analysis method was used to pool estimates. ResultsWe included 27 studies reporting data from a pooled population of 819,380 patients. The prevalence rates were 11.3% for pre-existing AF, 4.7% for newly diagnosed AF, and 13.2% for prevalent (total) AF. Predictors of newly diagnosed AF (from one study) included congestive heart failure (adjusted odds ratio [aOR] 3.33, 95% CI: 1.81–6.12), ischemic heart disease (aOR 3.25, 95% CI: 1.65–6.39), massive PE (aOR 2.67, 95% CI: 1.19–5.99). Overall, AF was associated with increased risk of short-term (aOR 1.54, 95% CI: 1.44–1.64) and long-term mortality (aOR 1.58, 95% CI: 1.26–1.97). In subgroup analyses, all types of AF were associated with increased risk of short-term mortality: pre-existing AF (aOR 1.90, 95% CI: 1.59–2.27), newly diagnosed AF (aOR 1.51, 95% CI: 1.18–1.93), and prevalent AF (aOR 1.50, 95% CI: 1.42–1.60). Pre-existing AF (aOR 2.08, 95% CI: 1.27–3.42) and prevalent AF (aOR 1.29, 95% CI: 1.02–1.63) were also associated with higher long-term mortality. ConclusionAF is present in about one in eight patients with aPE, and is associated with increased short- and long-term mortality. AF might improve risk stratification in patients with aPE.